Additionally, high level of ONECUT2 in primary adenocarcinoma is a strong predictor of poor outcome as measured by biochemical recurrence-free survival in two clinical cohorts (Supplementary Figure 3b). The gene discussed is ONECUT2; the disease is adenocarcinoma.